StockData
Estrella Immunopharma, Inc. logo

Estrella Immunopharma, Inc. (ESLAW) stock

ESLAWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as ESLA
Số liệu tài chính tới Q1 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.06−0.03 (-28.82%)

Close on Nov 17, 2026Market cap $14.42MP/E –Yield –

Estrella Immunopharma ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

No ebitda figures for Estrella Immunopharma

Estrella Immunopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Estrella Immunopharma figures

See a number that looks wrong?